The Ensign Group, Inc. $ENSG Stake Boosted by Capital Research Global Investors

Capital Research Global Investors increased its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,016,101 shares of the company’s stock after purchasing an additional 136,260 shares during the period. Capital Research Global Investors owned about 3.48% of The Ensign Group worth $348,322,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. CWM LLC raised its holdings in The Ensign Group by 8.4% during the third quarter. CWM LLC now owns 732 shares of the company’s stock valued at $126,000 after buying an additional 57 shares in the last quarter. Profund Advisors LLC raised its holdings in The Ensign Group by 2.5% in the 3rd quarter. Profund Advisors LLC now owns 2,378 shares of the company’s stock valued at $411,000 after acquiring an additional 59 shares in the last quarter. UMB Bank n.a. raised its stake in shares of The Ensign Group by 7.3% in the third quarter. UMB Bank n.a. now owns 911 shares of the company’s stock valued at $157,000 after purchasing an additional 62 shares in the last quarter. HB Wealth Management LLC lifted its holdings in shares of The Ensign Group by 4.1% during the 3rd quarter. HB Wealth Management LLC now owns 1,810 shares of the company’s stock worth $313,000 after acquiring an additional 72 shares during the period. Finally, Campbell Newman Asset Management Inc. boosted its holdings in The Ensign Group by 0.4% during the third quarter. Campbell Newman Asset Management Inc. now owns 19,480 shares of the company’s stock valued at $3,366,000 after purchasing an additional 79 shares in the last quarter. 96.12% of the stock is owned by institutional investors and hedge funds.

The Ensign Group Stock Down 0.2%

ENSG stock opened at $209.65 on Wednesday. The company has a market cap of $12.14 billion, a price-to-earnings ratio of 35.90, a P/E/G ratio of 2.06 and a beta of 0.83. The Ensign Group, Inc. has a twelve month low of $118.73 and a twelve month high of $218.00. The business has a 50 day moving average price of $192.08 and a two-hundred day moving average price of $182.23. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.07. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the firm posted $1.49 earnings per share. The company’s quarterly revenue was up 20.2% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. Analysts anticipate that The Ensign Group, Inc. will post 5.59 EPS for the current fiscal year.

The Ensign Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, January 31st. Shareholders of record on Wednesday, December 31st were paid a dividend of $0.065 per share. The ex-dividend date was Wednesday, December 31st. This is a boost from The Ensign Group’s previous quarterly dividend of $0.06. This represents a $0.26 annualized dividend and a yield of 0.1%. The Ensign Group’s dividend payout ratio is currently 4.45%.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, CFO Suzanne D. Snapper sold 4,573 shares of The Ensign Group stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $196.11, for a total transaction of $896,811.03. Following the transaction, the chief financial officer directly owned 272,889 shares of the company’s stock, valued at approximately $53,516,261.79. The trade was a 1.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Beverly B. Wittekind sold 500 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $210.23, for a total transaction of $105,115.00. Following the completion of the sale, the vice president directly owned 32,779 shares in the company, valued at approximately $6,891,129.17. This represents a 1.50% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 27,473 shares of company stock worth $5,167,422 over the last quarter. 3.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Royal Bank Of Canada reissued an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. UBS Group set a $230.00 price objective on The Ensign Group and gave the stock a “buy” rating in a research report on Friday, February 6th. Weiss Ratings reiterated a “buy (b)” rating on shares of The Ensign Group in a research report on Thursday, January 22nd. Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 6th. Finally, Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, The Ensign Group currently has a consensus rating of “Buy” and a consensus price target of $204.60.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.